Programming oncology specific Clinical Data Interchange Standards Consortium
    (CDISC) compliant Analysis Data Model (ADaM) datasets in 'R'. ADaM datasets are a
    mandatory part of any New Drug or Biologics License Application submitted to the
    United States Food and Drug Administration (FDA). Analysis derivations are
    implemented in accordance with the "Analysis Data Model Implementation Guide"
    (CDISC Analysis Data Model Team (2021), <https://www.cdisc.org/standards/foundational/adam>).
    The package is an extension package of the 'admiral' package.

Aids the programming of Clinical Data Standards Interchange
    Consortium (CDISC) compliant Ophthalmology Analysis Data Model (ADaM)
    datasets in R. ADaM datasets are a mandatory part of any New Drug or
    Biologics License Application submitted to the United States Food and
    Drug Administration (FDA). Analysis derivations are implemented in
    accordance with the "Analysis Data Model Implementation Guide" (CDISC
    Analysis Data Model Team, 2021,
    <https://www.cdisc.org/standards/foundational/adam/adamig-v1-3-release-package>).

A toolbox for programming Clinical Data Standards Interchange
    Consortium (CDISC) compliant Analysis Data Model (ADaM) datasets in R.
    ADaM datasets are a mandatory part of any New Drug or Biologics
    License Application submitted to the United States Food and Drug
    Administration (FDA). Analysis derivations are implemented in
    accordance with the "Analysis Data Model Implementation Guide" (CDISC
    Analysis Data Model Team, 2021,
    <https://www.cdisc.org/standards/foundational/adam>). The package is
    an extension package of the 'admiral' package for pediatric clinical
    trials.

Programming vaccine specific Clinical Data Interchange
    Standards Consortium (CDISC) compliant Analysis Data Model (ADaM)
    datasets in 'R'. Flat model is followed as per Center for Biologics
    Evaluation and Research (CBER) guidelines for creating vaccine
    specific domains. ADaM datasets are a mandatory part of any New Drug
    or Biologics License Application submitted to the United States Food
    and Drug Administration (FDA). Analysis derivations are implemented in
    accordance with the "Analysis Data Model Implementation Guide" (CDISC
    Analysis Data Model Team (2021),
    <https://www.cdisc.org/standards/foundational/adam/adamig-v1-3-release-package>).
    The package is an extension package of the 'admiral' package.